Munk School of Global Affairs, 1 Devonshire Place
  • November 9, 2015 from 7:00pm to 8:30pm

A conversation with two global thought leaders on cannabis research and policy

What does the research say about the harms of cannabis use? And how should this knowledge be applied to inform cannabis policy? UK expert Dr. David Nutt studies the impacts of cannabis use on the brain. CAMH’s Dr. Jürgen Rehm analyzes drug harms at a population level. Each will present the evidence from their area of research and the policy implications – and then the audience will be invited to join the conversation, in a discussion moderated by CBC’s Paul Kennedy.

Dr. David Nutt, Edmond J Safra Professor of Neuropsychopharmacology, Head of the Centre for Neuropsychopharmacology, Hammersmith Hospital, Imperial College London, U.K., and President, European Brain Council

Dr. Jürgen Rehm, Director, Social and Epidemiological Research and Senior Scientist, Campbell Family Mental Health Research Institute, CAMH, and Chair, Addiction Policy, Dalla Lana School of Public Health, University of Toronto

Moderated by Paul Kennedy, Host, CBC Ideas

All are welcome.

Hosted by the Centre for Addiction and Mental Health (CAMH)